Fig 4.

Psoriasis and atopic dermatitis. Clinician interest levels in using a predictive biomarker test providing guidance on therapy selection for patients with atopic dermatitis or psoriasis (N = 265). Respondents were asked to rate how useful they would find a personalized molecular test informing on therapy selection for patients with moderate-to-severe atopic dermatitis or psoriasis. Responses were rated on a 5-point Likert scale from useful (“yes”), “likely” useful, “not likely” useful, “not sure”, to not useful (“no”).